Our CEO was recently asked how far away is fully computational drug discovery and development. This isn’t an easy question to answer and Andrew doesn’t provide an exact date. However, he does provide interesting insight into the progress we’ve made and the challenges ahead. Give his response a listen below.

As Andrew explains, the first step is proving that computational drug discovery works. Currently, there are a drugs in clinical trials, but none on the market. Additionally, there’s the question of how we substitute in vitro and vivo tests for in silico tests. However, the biggest hurdle we’ll likely face, in a push towards fully computational drug discovery, is industry skepticism.